CARSON VALLEY MEDICAL CENTER
1. Target Overview & Investment Thesis
CARSON VALLEY MEDICAL CENTER is a 23-bed suburban community hospital in DOUGLAS, NV with $84.3M in net patient revenue and a 6.8% operating margin. The hospital serves a payer mix of 48.3% Medicare, 8.6% Medicaid, and 43.1% commercial.
Thesis: Turnaround. Our ML models identify $6.2M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 6.8% to 14.1% (+736bps).
| Net Revenue HCRIS | $84.3M |
| Current EBITDA COMPUTED | $5.7M |
| Operating Margin COMPUTED | 6.8% |
| Occupancy HCRIS | 47.2% |
| Revenue / Bed COMPUTED | $3.7M |
| Net-to-Gross HCRIS | 31.4% |
| Distress Probability ML | 47.1% |
2. Market Context & Competitive Position
NV has 58 Medicare-certified hospitals with a median operating margin of 0.4%. The target's margin of 6.8% places it above the state median. Among 15 size-comparable peers (12-46 beds), the median margin is -4.2%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (12-46), prioritizing same-state peers. 15 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| CARSON VALLEY MEDICAL CENTER (Target) | NV | 23 | $84.3M | 6.8% |
| BANNER CHURCHILL COMMUNITY HOS | NV | 25 | $69.2M | 6.8% |
| DIGINTY HEALTH ST ROSE DOMINIC | NV | 32 | $61.5M | 12.2% |
| HUMBOLDT GENERAL HOSPITAL | NV | 25 | $58.8M | -37.3% |
| PAM REHAB HOSP OF CENTENNIAL H | NV | 44 | $35.7M | 29.1% |
| WILLIAM BEE RIRIE HOSPITAL | NV | 25 | $35.1M | -17.9% |
| MESA VIEW REGIONAL HOSPITAL | NV | 25 | $34.9M | -4.2% |
| DESERT VIEW REGIONAL MEDICAL C | NV | 25 | $34.4M | 2.0% |
| BOULDER CITY HOSPITAL | NV | 25 | $30.7M | -13.8% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $6.2M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $1.8M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $1.7M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $1.7M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $1.0M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $54K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $5.7M |
| + RCM Uplift | +$6.2M |
| Pro Forma EBITDA | $11.9M |
| Current Margin | 6.8% |
| Pro Forma Margin | 14.1% |
| WC Released (1x) | $3.2M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $8.8M | $99.6M | 11.37x | 62.6% |
| Base (11x exit) | 10.0x | 11.0x | $8.8M | $112.4M | 12.83x | 66.6% |
| Bull Case | 9.0x | 11.0x | $7.9M | $135.8M | 17.22x | 76.7% |
| Bull (12x exit) | 9.0x | 12.0x | $7.9M | $150.4M | 19.08x | 80.3% |
| Bear Case | 11.0x | 10.0x | $9.6M | $65.7M | 6.82x | 46.8% |
| Bear (11x exit) | 11.0x | 11.0x | $9.6M | $75.5M | 7.83x | 50.9% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Standard execution risk | RCM improvement requires management buy-in and 12-18 month implementation timeline |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 15 hospitals with 12-46 beds
- Same-state prioritization (n=16)
- Comp margins: P25=-18.8% / P50=-4.2% / P75=9.3%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.